← Back to Search

MEMR Diagnostic Evaluation for Hearing Disorders (WAI-MEMR Trial)

N/A
Waitlist Available
Research Sponsored by Mimosa Acoustics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Normal hearing or hearing loss
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 2 years
Awards & highlights
No Placebo-Only Group

Summary

This project will assess the middle-ear muscle reflex using wideband acoustic immittance which is a valuable method for evaluating infants, children, and adults. The developments will facilitate clinical applications that include hearing screening and diagnostic evaluation of persons of all ages with normal hearing and with hearing loss.

Eligible Conditions
  • Hearing Disorders
  • Hearing Loss

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
WAI-MEMR

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: MEMR Diagnostic EvaluationExperimental Treatment1 Intervention
Middle Ear Muscle Reflex using wideband acoustic reflectance to assess hearing status.

Find a Location

Who is running the clinical trial?

Mimosa AcousticsLead Sponsor
Vanderbilt University Medical CenterOTHER
900 Previous Clinical Trials
939,180 Total Patients Enrolled
~69 spots leftby Nov 2025